Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation on collagen via integrin αiIbβ3 activation

Transfusion

Volumn 54, Issue 7, 2014, Pages 1808-1816

  Terada, Chikahiro ^a   Mori, Junpei ^a   Okazaki, Hitoshi ^a   Satake, Masahiro ^a   Tadokoro, Kenji ^a  

^a SUWA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN; INTEGRIN; INTEGRIN ALPHA2BBETA3; MANGANESE; RIBOFLAVIN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; BLOOD STORAGE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; NORMAL HUMAN; PATHOGEN REDUCTION SYSTEM; PROTEIN BINDING; SHEAR RATE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; ULTRAVIOLET RADIATION;

BLOOD PLATELETS; COLLAGEN; FIBRINOGEN; HUMANS; MANGANESE; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELETPHERESIS; PROTEIN BINDING; RIBOFLAVIN; THROMBOSIS; ULTRAVIOLET RAYS;

EID: 84904515234     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12566     Document Type: Article

References (33)

1. Blajchman MA, Goldman M, Baeza F,. Improving the bacteriological safety of platelet transfusion. Transfus Med Rev 2004; 18: 11-24.
2. Solheim BG, Seghatchian J,. The six questions of pathogen reduction technology: an overview of current opinions. Transfus Apher Sci 2008; 39: 51-57.
3. Kumar V, Lockerbie O, Keil SD, et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004; 80: 15-21.
4. Goodrich RP, Edrich RA, Li J, et al. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006; 35: 5-17.
5. Hervig T, Seghatchian J, Apelseth TO,. Current debate on pathogen inactivation of platelet concentrates-to use or not to use? Transfus Apher Sci 2010; 43: 411-414.
6. Picker SM, Steisel A, Gathof BS,. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Transfusion 2008; 48: 1685-1692.
7. Li J, Lockerbie O, de Korte D, et al. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion 2005; 45: 920-926.
8. Picker SM, Steisel A, Gathof BS,. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: results of a three-arm in vitro study. Transfus Apher Sci 2009; 40: 79-85.
9. 2) for pathogen-reduction. Vox Sang 2009; 97: 26-33.
10. Picker SM, Schneider V, Gathof BS,. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies. Transfusion 2009; 49: 1224-1232.
11. Perez-Pujol S, Tonda R, Lozano M, et al. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005; 45: 911-919.
12. AuBuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005; 45: 1335-1341.
13. Cazenave JP, Folléa G, Bardiaux L, et al. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2011; 50: 2362-2375.
14. Johansson PI, Simonsen AC, Brown PN, et al. A pilot study to assess the hemostatic function of pathogen-reduced platelets in patients with thrombocytopenia. Transfusion 2013; 53: 2043-2052.
15. Schubert P, Culibrk B, Coupland D, et al. Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage. Transfusion 2012; 52: 397-408.
16. Polanowska-Grabowska R, Gear AR,. High-speed platelet adhesion under conditions of rapid flow. Proc Natl Acad Sci U S A 1992; 89: 5754-5758.
17. Polanowska-Grabowska R, Gear AR,. Role of cyclic nucleotides in rapid platelet adhesion to collagen. Blood 1994; 83: 2508-2515.
18. Litvinov RI, Nagaswami C, Vilaire G, et al. Functional and structural correlations of individual αIIbβ3 molecules. Blood 2004; 104: 3979-3985.
19. Blue R, Li J, Steinberger J, et al. Effects of limiting extension at the alphaIIb genu on ligand binding to integrin αIIbβ3. J Biol Chem 2010; 285: 17604-17613.
20. Colton T,. Statistics in medicine. Boston (MA): Little, Brown and Company; 1974.
21. Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004; 44: 877-885.
22. Verhaar R, Dekkers DW, De Cuyper IM, et al. UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood 2008; 112: 4935-4939.
23. Zhi L, Chi X, Gelderman MP, et al. Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model. Transfusion 2013; 53: 722-731.
24. Malaver E, Romaniuk MA, D'Atri LP, et al. NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost 2009; 7: 1333-1343.
25. Takagi J, Petre BM, Walz T, et al. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002; 110: 599-611.
26. Bunch TA,. Integrin alphaIIbbeta3 activation in Chinese hamster ovary cells and platelets increases clustering rather than affinity. J Biol Chem 2010; 285: 1841-1849.
27. Jackson SP,. The growing complexity of platelet aggregation. Blood 2007; 109: 5087-5095.
28. Haling JR, Monkley SJ, Critchley DR, et al. Talin-dependent integrin activation is required for fibrin clot retraction by platelets. Blood 2011; 117: 1719-1722.
29. Zhang G, Xiang B, Ye S, et al. Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling. J Biol Chem 2011; 286: 39466-39477.
30. Kamae T, Shiraga M, Kashiwagi H, et al. Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation. J Thromb Haemost 2006; 4: 1379-1387.
31. Tadokoro S, Nakazawa T, Kamae T, et al. A potential role for α-actinin in inside-out αIIbβ3 signaling. Blood 2011; 117: 250-258.
32. Kamata T, Handa M, Ito S, et al. Structural requirements for activation in alphaIIb beta3 integrin. J Biol Chem 2010; 285: 38428-38437.
33. Arthur JF, Qiao J, Shen Y, et al. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J Thromb Haemost 2013; 10: 1133-1141.